» Articles » PMID: 29758490

Lung Cancer Incidence Trends in Uruguay 1990-2014: An Age-period-cohort Analysis

Overview
Publisher Elsevier
Specialties Oncology
Public Health
Date 2018 May 15
PMID 29758490
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Uruguay, a country with one of the highest lung cancer rates worldwide, initiated a series of comprehensive anti-smoking measures in 2005. We assess the tobacco control policies in the context of cohort-driven lung cancer incidence trends over a 25-year period, providing baseline predictions to 2035.

Methods: Using data from the National Cancer Registry of Uruguay, an age-period-cohort analysis of trends 1990-2014 was performed. The NORDPRED package was used to predict the annual number of new cases of lung cancer and incidence rates up to 2035.

Results: In men, age-standardised (world) rates declined from a peak of 165.6 in 1995 to 103.1 by 2014, translating to a 70% reduction in the risk of lung cancer in men born in 1970 relative to the early-1940s. In females, rates increased steadily from 18.3 in 1991 to 30.0 by 2014, with successive increases in risk among generations of women born 1940-1960. There is however evidence of a decline in observed rates in women born recently. Extrapolations of the trends indicate an 8% reduction in the mean number of new lung cancer cases in men by 2035, but a 69% increase in women.

Conclusion: Despite observed and predicted reductions in lung cancer incidence in Uruguayan men, rates among women are set to continue to increase, with a large rise in the annual number of female lung cancer diagnoses expected before 2035. There are signals of a diminishing risk among recent generations of women born after 1960. The current analysis provides important baseline information in assessing the future impact of the recent tobacco control initiatives in Uruguay.

Citing Articles

The risk of solid organ tumors in patients with chronic kidney disease: A narrative review of literature.

Al-Qudimat A, Altahtamoun S, Kilic F, Al-Zoubi R, Al Zoubi M Heliyon. 2024; 10(13):e32822.

PMID: 39035535 PMC: 11259794. DOI: 10.1016/j.heliyon.2024.e32822.


Bronchoalveolar Lavage as Potential Diagnostic Specimens to Genetic Testing in Advanced Nonsmall Cell Lung Cancer.

Lin X, Cai Y, Zong C, Chen B, Shao D, Cui H Technol Cancer Res Treat. 2023; 22:15330338231202881.

PMID: 37743841 PMC: 10521282. DOI: 10.1177/15330338231202881.


NOTCH4 sensitizes lung adenocarcinomas to EGFR-TKIs through transcriptional down-regulation of HES1.

Zhang B, Dong S, Wang J, Huang T, Zhao P, Xu J Nat Commun. 2023; 14(1):3183.

PMID: 37268635 PMC: 10238419. DOI: 10.1038/s41467-023-38833-7.


Targeting Cancer Stem Cells as the Key Driver of Carcinogenesis and Therapeutic Resistance.

Eid R, Alaa Edeen M, Shedid E, Kamal A, Warda M, Mamdouh F Int J Mol Sci. 2023; 24(2).

PMID: 36675306 PMC: 9861138. DOI: 10.3390/ijms24021786.


Disparities in thoracic surgical oncology.

Williams B, McAllister M, Erkmen C, Mody G J Surg Oncol. 2023; 127(2):329-335.

PMID: 36630104 PMC: 10714123. DOI: 10.1002/jso.27180.